BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27591792)

  • 1. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition.
    Osajima T; Hoshino T
    Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Binding Modes of Antigen-Antibody Complexes by Molecular Mechanics Calculation.
    Qu L; Qiao X; Qi F; Nishida N; Hoshino T
    J Chem Inf Model; 2021 May; 61(5):2396-2406. PubMed ID: 33934602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational and statistical study on the molecular interaction between antigen and antibody.
    Osajima T; Suzuki M; Neya S; Hoshino T
    J Mol Graph Model; 2014 Sep; 53():128-139. PubMed ID: 25123651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
    Tsuchiya Y; Mizuguchi K
    Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.
    Wang X; Singh SK; Kumar S
    Pharm Res; 2010 Aug; 27(8):1512-29. PubMed ID: 20422267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies.
    Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR
    MAbs; 2022; 14(1):2024118. PubMed ID: 35090383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Framework Residue H71 Results in Different Antibody Paratope States in Solution.
    Fernández-Quintero ML; Kroell KB; Hofer F; Riccabona JR; Liedl KR
    Front Immunol; 2021; 12():630034. PubMed ID: 33737932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
    Barrios Y; Jirholt P; Ohlin M
    J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
    Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
    J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repertoire Analysis of Antibody CDR-H3 Loops Suggests Affinity Maturation Does Not Typically Result in Rigidification.
    Jeliazkov JR; Sljoka A; Kuroda D; Tsuchimura N; Katoh N; Tsumoto K; Gray JJ
    Front Immunol; 2018; 9():413. PubMed ID: 29545810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDR-H3 loop ensemble in solution - conformational selection upon antibody binding.
    Fernández-Quintero ML; Kraml J; Georges G; Liedl KR
    MAbs; 2019; 11(6):1077-1088. PubMed ID: 31148507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of CDR H3 structural diversity.
    Weitzner BD; Dunbrack RL; Gray JJ
    Structure; 2015 Feb; 23(2):302-11. PubMed ID: 25579815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.